Physician profile
Michael P Weinstein
NPI 1972531929
$3,573.70
in general payments reported to CMS, 2019-2025
12 companies · $3,161 in 2025
The $3,161 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $136 · 2021: $39.79 · 2022: $32.53 · 2025: $3,161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $3,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $3,161.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Health Care Systems INC. | $3,161.28 | 2025 | |
| Surgalign Spine Technologies, INC. | $152.94 | 2019-2021 | |
| Stryker Corporation | $49.83 | 2019 | |
| Cerapedics INC. | $32.53 | 2022 | |
| Zimmer Biomet Holdings, INC. | $31.75 | 2019 | |
| Medtronic USA, INC. | $28.33 | 2019 | |
| Horizon Therapeutics Plc | $25.00 | 2020 | |
| Pacira Therapeutics, INC. | $23.72 | 2020 | |
| Fidia Pharma USA INC. | $23.29 | 2019 | |
| Pfizer INC. | $17.01 | 2019 | |
| Smith+Nephew, INC. | $16.30 | 2021 | |
| Zyla Life Sciences, INC. | $11.72 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.